According to the new market research report Coagulation Analyzer Market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. Over the last two decades, hemostasis analyzers and reagents have witnessed significant innovations.
Download Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=197226392
This is transforming the practice of hemostasis testing throughout the world. North America and a major part of the Western European region are saturated markets for hemostasis products. However, developing regions such as Asia-Pacific (China and India), Latin America, and the Middle East are expected to form the new revenue pockets for this market. The hemostasis analyzers and reagents market in these emerging regions is primarily driven by various economic developments. Moreover, the presence of a large patient population, increasing funding/investment towards the development of hemostasis products, growing focus of both international and domestic players on the Asia-Pacific Coagulation Analyzer Market, and a large number of R&D activities are the key factors fueling the growth of the Coagulation Analyzer Market in these regions.
Moreover, these regions provide favorable conditions for the growth of market players and have a high demand for hemostasis products. As a result of this, several players in the Coagulation Analyzer Market are investing in emerging economies. For instance, in May 2014, Sysmex Corporation expanded its reagent factories in Singapore. This expansion enabled Sysmex to provide a stable supply of reagents. It also helped the company to cater to the growing demand for reagents and increase its market share in Singapore. Similarly, in May 2012, Siemens announced plans to expand its presence in Brazil. The company intended to invest $1 billion by 2013. The investment will be spread across all of Siemens’ business segments, namely Energy, Industry, Infrastructure & Cities, and Healthcare Sectors.
Get Sample Pages: https://www.marketsandmarkets.com/requestsample.asp?id=197226392
In order to leverage the high growth
potential in the coagulation analyzer market in emerging economies, various
domestic and international players are increasingly focusing on the launch of
technologically advanced products. For instance, in September 2014, Sysmex
Corporation launched CS-2400/2500, which is an automated blood coagulation
analyzer. Similarly, in January 2013, Siemens Healthcare Diagnostics introduced
the Sysmex CS-5100 System, a random-access high-volume coagulation analyzer.
The Sysmex CS-5100 System is integrated with simultaneous, multi-wavelength
Preanalytical Sample Integrity (PSI) technology, facilitating high-volume labs
to attain first-run accuracy by recognizing and managing inappropriate test
specimens prior to analysis. The launch of this new coagulation analyzer was a
manifestation of Siemens’ efforts to nurture its innovative capacity, which was
an objective of Siemens Agenda 2013 program.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062